• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

A bold winning move? Hyundai Motor enters 'post-China' Indian stock market

곽호룡 기자

horr@fntimes.com

기사입력 : 2024-10-22 18:44 최종수정 : 2024-10-23 16:13

No. 2 Market Raises KRW 4 Trillion Through Short Sale Of 17.5% Stake In Indian Corporation
Sold 600,000 units last year, plans to build a production base for 1 million units next year
Aiming for No. 1 in electrification

Hyundai Motor Group Chairman Chung Eui-sun (C) visits Hyundai Motor's Chennai plant in India on Aug. 8, 2023. Photo: Hyundai Motor

Hyundai Motor Group Chairman Chung Eui-sun (C) visits Hyundai Motor's Chennai plant in India on Aug. 8, 2023. Photo: Hyundai Motor

이미지 확대보기
[Korea Financial Times, Gwak Horyung] Hyundai Motor will enter the Indian stock market on the 22nd. Along with the high growth expectations of the Indian automobile industry, the importance of India has rapidly emerged in Hyundai Motor's overseas strategy.

India is Hyundai's second largest overseas market after the United States. It has become even more important since China's slowing growth and Russia's withdrawal. Hyundai Motor India (HMI) had sales of KRW 10.63 trillion last year. It is the third largest after the United States (HMA, KRW 40.82 trillion) and Europe (HME, KRW 17.66 trillion). HMI's net profit was KRW 921.1 billion, second only to the United States (KRW 2.78 trillion), and more than the combined net profit of its five overseas subsidiaries, excluding China (KRW 517 billion).

Chart prepared by = Korea Financial Times

Chart prepared by = Korea Financial Times

Chart prepared by = Korea Financial Times

Chart prepared by = Korea Financial Times


Hyundai broke its annual sales record last year, selling 602,111 vehicles. Its market share was 14.6 %, ranking it second in the industry. The top spot went to Maruti Suzuki, an Indo-Japanese joint venture that first listed on the Indian stock market in 2003. Hyundai is the second automaker to list on the Indian stock market.

Hyundai aims to establish an annual production system of 1 million vehicles in India in the second half of next year. In addition to its existing Chennai plant (824,000 units), it will start up its Pune plant, which it acquired from GM last year.

In addition, the company has a blueprint to take the lead in the industry transition by introducing five EV models by 2030, including the strategic EV Creta EV. The strategy is not only to sell electric vehicles but also to lead the construction of an electrification ecosystem by expanding electric vehicle charging stations and collaborating with an Indian battery company (Exide Energy).

Hyundai Motor India's IPO last week was a success and is expected to raise around KRW 4.5 trillion. It is the largest IPO in the history of the Indian stock market. Hyundai Motor conducted the IPO by publicly selling 17.5% of its 100% stake in Indian subsidiaries, not issuing new shares. It prioritized raising cash that it could get its hands on immediately.

Some say that Hyundai Motor's preemptive entry into the Indian stock market is an adventurer. Despite India's growth potential, local political and labor risks are also a reason why global companies are reluctant to enter the country directly. GM's withdrawal from India was ostensibly due to poor profitability, but local policy uncertainty also played a role.

Gwak Horyung (horr@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 Kia's Three Growth Engines Fuel Its Historic Charge Toward No. 1 The long-standing formula of South Korea's auto market — Hyundai Motor No. 1, Kia No. 2 — is showing cracks. Kia has narrowed the sales gap with Hyundai Motor to within striking distance, and forecasts that it will claim the top spot in domestic sales for the first time in its history this year are increasingly becoming reality.Kia's sales momentum is attributed to solid performance in its core SUV lineup, combined with the successful rollout of new lineups such as mass-market electric vehicle (EV) models and purpose-built vehicles (PBVs).According to Kia's disclosure on the 28th, the compan 2 SK Biopharmaceuticals Doubles Down: $795M Bet on Second Blockbuster Epilepsy Drug "SK Biopharmaceuticals has now entered a different league, one in which we compete directly with global big pharma companies in the United States and Europe, not just in Korea."President Lee Dong-hoon of SK Biopharmaceuticals made this declaration at a press conference held on the afternoon of the 26th at the Westin Josun Hotel in Jung-gu, Seoul, where he abruptly unveiled the company's license-in (L/I) agreement to acquire opakalim, an epilepsy drug candidate from Ireland-based Biohaven.Through the deal, SK Biopharmaceuticals aims to reduce its reliance on a single product — cenobamate — an 3 Naver Bets on AI Infrastructure While Kakao Bets on Agentic AI South Korea's two leading platform companies, Naver and Kakao, are maintaining similar levels of research and development (R&D) investment relative to revenue in the first half of this year, but they are pursuing markedly different strategies to secure AI competitiveness.Naver is focused on expanding AI infrastructure, while Kakao — taking its spinoff as an opportunity — is concentrating on strengthening agentic AI services.According to the Financial Supervisory Service's electronic disclosure system on the 24th, Naver's and Kakao's R&D spending in the first half of 2026 came to KRW
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략
[그래픽 뉴스] 퇴근 후 주차했는데 수익 발생? V2G의 정체

FT도서

더보기